If you made any changes in Pure these will be visible here soon.

Research Output


Repurposing auranofin to treat TP53-mutated or PTEN-deleted refractory B-cell lymphoma

Wang, J., Wang, J., Lopez, E., Guo, H., Zhang, H., Liu, Y., Chen, Z., Huang, S., Zhou, S., Leeming, A., Zhang, R. J., Jung, D., Shi, H., Grundman, H., Doakes, D., Cui, K., Jiang, C., Ahmed, M., Nomie, K., Fang, B. & 3 others, Wang, M., Yao, Y. & Zhang, L., Dec 1 2019, In : Blood Cancer Journal. 9, 12, 95.

Research output: Contribution to journalLetter

Open Access

Immune regulatory effects of panobinostat in patients with Hodgkin lymphoma through modulation of serum cytokine levels and T-cell PD1 expression

Oki, Y., Buglio, D., Zhang, J., Ying, Y., Zhou, S., Sureda, A., Ben-Yehuda, D., Zinzani, P. L., Prince, H. M., Harrison, S. J., Kirschbaum, M., Johnston, P. B., Shen, A., Von Tresckow, B. & Younes, A., Aug 2014, In : Blood Cancer Journal. 4, 8, e236.

Research output: Contribution to journalLetter

30 Scopus citations